PSC
LMAT icon

Piper Sandler & Co’s LeMaitre Vascular LMAT Stock Holding History

Piper Sandler & Co’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-33,500
Closed -$256K – 133
2014
Q4 		$256K Buy
+33,500
New +$240K 0.12% 72

Other funds holding LMAT

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Piper Sandler & Co's LMAT Position: Q1 2015 in Review

Piper Sandler & Co sold out of LeMaitre Vascular (LMAT) in Q1 2015, closing a stake of 33,500 shares — an estimated $256K sold.

Piper Sandler & Co first reported a position in LMAT in Q4 2014 and held it in 1 quarter. The position peaked at $256K in Q4 2014. 50 funds tracked by Wall St. Rank hold LMAT as of Q1 2015.

  • Piper Sandler & Co reported no remaining LeMaitre Vascular position as of Q1 2015 after selling out during the quarter.
  • Piper Sandler & Co sold 33,500 LeMaitre Vascular shares in Q1 2015, an estimated $256K.
  • Piper Sandler & Co first reported a position in LeMaitre Vascular in Q4 2014 and held it in 1 quarter.
  • Piper Sandler & Co's LeMaitre Vascular position peaked at $256K in Q4 2014.
  • 50 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2015.

Based on Piper Sandler & Co's 13F filing for Q1 2015, filed 15 May 2015.